|
Charcot-Marie-Tooth Disorder Reviewed 07-08-2002 Get Web page suited for printing Email this to a friend or colleague Studies with patients Table of Contents (click to jump to sections) What is Charcot-Marie-Tooth Disorder?Is there any treatment? What is the prognosis? What research is being done? Organizations Related NINDS Publications and Information What is Charcot-Marie-Tooth Disorder? Charcot-Marie-Tooth disorder (CMT) is an inherited neurological disease characterized by a slowly progressive degeneration of the muscles in the foot, lower leg, hand, and forearm, and a mild loss of sensation in the limbs, fingers, and toes. The first sign of CMT is generally a high arched foot or gait disturbances. Other symptoms of the disorder may include foot bone abnormalities such as high arches and hammer toes, problems with hand function and balance, occasional lower leg and forearm muscle cramping, loss of some normal reflexes, occasional partial sight and/or hearing loss, and, in some patients, scoliosis (curvature of the spine). CMT is a disorder of genetic heterogeneity, in which mutations in different genes can produce the same clinical symptoms. In CMT, there are not only different genes but different patterns of inheritance. The most common type, CMT1A, is inherited in an autosomal dominant pattern. This means that if one parent has CMT there is a 50 percent chance of passing the disease on to each child. Other types are autosomal recessive or sex-linked CMT. Each type is characterized by symptoms ranging from severe weakness and wasting of leg and hand muscles to very mild symptoms or no symptoms at all. Full expression of CMT's clinical symptoms generally occurs by age 30. The more severe symptoms are related to an earlier age of onset. Is there any treatment? What is the prognosis? What research is being done? Charcot-Marie-Tooth Association (CMTA)
Muscular Dystrophy Association Related NINDS Publications and Information
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history. All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated. Provided by: | |||